v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Operating activities    
Net income (loss) $ 8,975 $ (78,722)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 56,184 34,146
Amortization of intangible assets 8,276 8,192
Amortization of deferred contract acquisition costs 112,877 77,554
Non-cash operating lease cost 6,331 4,524
Stock-based compensation expense 295,633 234,044
Deferred income taxes (352) 1,604
Non-cash interest expense 1,531 1,366
Change in fair value of strategic investments 0 (4,128)
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 86,718 (50,728)
Deferred contract acquisition costs (122,007) (108,940)
Prepaid expenses and other assets (26,338) (10,938)
Accounts payable (2,982) 794
Accrued expenses and other liabilities 4,935 5,723
Accrued payroll and benefits (30,161) 245
Operating lease liabilities (6,475) (4,704)
Deferred revenue 152,528 314,831
Net cash provided by operating activities 545,673 424,863
Investing activities    
Purchases of property and equipment (102,681) (118,339)
Capitalized internal-use software and website development costs (25,975) (13,235)
Purchases of strategic investments (12,177) (7,825)
Purchases of intangible assets (500) (700)
Proceeds from maturities and sales of short-term investments 250,000 0
Purchases of deferred compensation investments (876) 0
Net cash provided by (used in) investing activities 107,791 (140,099)
Financing activities    
Proceeds from issuance of common stock upon exercise of stock options 4,125 4,919
Proceeds from issuance of common stock under the employee stock purchase plan 45,432 34,445
Capital contributions from non-controlling interest holders 8,088 3,963
Net cash provided by financing activities 57,645 43,327
Effect of foreign exchange rates on cash, cash equivalents and restricted cash 1,083 (4,330)
Net increase in cash, cash equivalents and restricted cash 712,192 323,761
Cash, cash equivalents and restricted cash at beginning of period 2,456,924 1,996,633
Cash, cash equivalents and restricted cash at end of period 3,169,116 2,320,394
Cash and cash equivalents 3,167,215 2,318,858
Restricted cash included in prepaid expenses and other assets 1,901 1,536
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 3,169,116 2,320,394
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,289
Income taxes paid, net of refunds received 9,991 4,967
Supplemental disclosure of non-cash investing and financing activities:    
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses (20,089) 18,810
Vesting of early exercised stock options 0 1,470
Operating lease liabilities arising from obtaining operating right of-use assets 13,083 2,130
Purchases of intangible assets included in accrued expenses and other liabilities $ 26 $ 0